Jabbour, E., Baer, M. R., Hunter, A., Kim, D. D. H., Oehler, V. G., Guo, H., Chen, Z., Yang, Z., Fu, T., Yang, D., Zhai, Y., Kantarjian, H. M. (2026). Olverembatinib (HQP1351) combined with blinatumomab in patients with lymphoid blast phase chronic myeloid leukemia (CML-LBP) or Philadelphia chromosome–positive B-cell precursor acute lymphoblastic leukemia (Ph + BCP-ALL).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6513